Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus - Wikidata - awgldk - TriplyDB

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus

http://www.wikidata.org/entity/Q35173733

about

Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines Balancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza Infection Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head Universal immunity to influenza must outwit immune evasion Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.Diet-induced obese mice exhibit altered heterologous immunity during a secondary 2009 pandemic H1N1 infection A GFP-tagged nucleoprotein-based aggregation assay for anti-influenza drug discovery and antibody development.MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection Vaccinia-based influenza vaccine overcomes previously induced immunodominance hierarchy for heterosubtypic protection.Primary and long-term B-cell responses in the upper airway and lung after influenza A virus infection.The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.Influenza vaccines: a moving interdisciplinary field.H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix(®) vaccination.Preexisting Antibody-Dependent Cellular Cytotoxicity-Activating Antibody Responses Are Stable Longitudinally and Cross-reactive Responses Are Not Boosted by Recent Influenza Exposure.Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism.Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza.Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model.Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice Subsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice.Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence.Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful.Mucosal immunization with integrase-defective lentiviral vectors protects against influenza virus challenge in mice Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic Prolonged antigen presentation by immune complex-binding dendritic cells programs the proliferative capacity of memory CD8 T cells.Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge.The pathogenesis of Rift Valley fever.Robust immunity and heterologous protection against influenza in mice elicited by a novel recombinant NP-M2e fusion protein expressed in E. coli A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection.Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses

P2860

Q26744622-111CCC65-E2EA-4D56-A60B-9EEFA776EC92 Q26767517-BF55B7F3-0212-47AC-9B10-BDD0E4DA9999 Q26783897-4E7D83D3-BE81-403E-8952-8164453B5403 Q26991896-1E03463A-F9D1-41BD-8B5A-0DF957FE856D Q30223058-9196C70B-0FB2-49F7-B96D-A67F458D3748 Q30352501-573FCFEF-1D64-4DBC-95EF-11FB10292536 Q30352981-68EC6680-C44D-43EF-9689-4180EF807A45 Q30358935-717AE59F-79F7-4057-96FB-6D76697A4FA8 Q30361079-C68CF518-BF4E-491E-B331-454F2413839A Q30362529-48185AAB-E0FB-485B-B6D3-44520A9460D0 Q30362668-C394905C-A7FC-4C65-9C1D-0F09B4B4CC25 Q30365366-5579ED1B-EE55-4278-8CB0-FA43508F1559 Q30367695-CBC8FED0-3E31-4A54-B6FB-4D5FE328BF14 Q30371297-52AA21DA-DB48-454F-8756-F191DBF1C009 Q30391515-AABD14D2-B355-4252-86B0-0AEDD93D15BC Q30395259-18D9E9B3-E286-48E6-9EA4-7D69D6832D19 Q30397362-9CF0D7FE-E9D9-4EED-B187-ED1449BD802C Q30400230-22654CB2-94D4-444B-9335-315E28A1443C Q30400347-72D23466-2697-474C-BB13-2AA17D10C419 Q30403507-3FB73E5A-7C92-480B-B858-382A2DA29B69 Q30405211-C9939FF5-94FE-46F4-807D-6A61DA8586AB Q30410126-7D1B7C17-1C99-4008-9623-5E3BB3CAED34 Q30416502-BEF31DCC-5CE5-443E-811A-296137998D46 Q30416598-A954FE5B-DB7D-4058-9815-5DC1C59C66EF Q30420397-37A74221-43BC-48F9-9D79-D3BFBA40668C Q30425194-8D502456-A747-4673-90E6-D749D48AD602 Q30429302-FE1C5AC7-F4C3-4A07-AFC5-21C7E0DAEBF7 Q30429719-72691A6C-546D-4F84-ADB5-DED13FD9F720 Q30431078-12C947CA-62ED-4BE6-BAC7-F7143674A87C Q33604567-F92C9D8B-8D70-432C-87F1-04D32A431F5E Q33867299-B4FD9568-FF68-4741-8E9B-6F89CF741632 Q33904286-F628DB52-330E-4EAC-AFA9-493860DFC307 Q33964275-D620AEAD-005C-42C4-A42A-7B23056677CF Q34031858-8FCA06F0-CEBB-4B11-9818-7DED2F9C9914 Q34070683-FDDCA34A-887B-42FE-B616-07EB34230EC0 Q34191969-330F0114-5660-4953-A8A2-1FF8918A30A1 Q34533990-DFC2E1E9-83BE-46F5-94A0-850E3D3C6197 Q34594671-472E18D5-B6AE-43C1-B919-688335D89EDB Q34629133-31ECDF28-70E1-40B4-92FE-BC2AF3F430C2 Q34634852-81E44B36-67F4-454A-940F-57D7F68BF00B

P2860

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus

http://www.wikidata.org/entity/Q35173733

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus

@ast

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus

@en

type

label

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus

@ast

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus

@en

prefLabel

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus

@ast

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus

@en

P1433

Q35173733-E7D1A991-6038-450C-9059-37FCFD32FCEB

P1476

Q35173733-A259C6A2-DE37-43F5-80D1-C9F1A35FDB2C

P2093

Q35173733-025FE23D-9A07-4F78-A0AD-D1379D2B216E

Q35173733-6550E4E5-DAB2-4F03-9731-ADC0A12A6C39

Q35173733-698C1E22-2D18-4BDB-81E2-2B3CBB87FDF9

Q35173733-BEF8B47E-9456-46A6-BE35-93972E6CFC33

Q35173733-D9BC1286-FE72-4D38-BB0E-6DDDCCE47AF0

Q35173733-DFB7685F-983B-4FD7-9B4E-0780261DFEFE

Q35173733-EDAEF7BE-58C3-4417-A730-BBE747DF127A

P2860

Q35173733-03BCEDCE-C985-452C-BC03-642889C78363

Q35173733-0BB5F51E-B5D3-43E8-BADF-28C37F931713

Q35173733-0D7046C6-15BC-45A9-9DC0-BD6972A36058

Q35173733-0D8A5D3C-3BEA-41E4-816A-0D37793AE8D5

Q35173733-1390FD7D-03A8-47AC-BE0E-5F845A0747C5

Q35173733-14957958-A916-4B11-941B-0929CD632DA6

Q35173733-14F7BC91-9788-4B62-B28E-00F1BF69C346

Q35173733-155011C4-9AE3-4091-BAB0-E81717755343

Q35173733-1663B0D6-467B-4170-A154-E842349FB39F

Q35173733-172D73DE-C1F5-4C77-B8E1-01DDE4555361

P304

Q35173733-5E2F47EA-0AAB-4209-874A-A8CB0F4F9EE2

P31

Q35173733-E2689268-B1BA-4136-BCE2-664512081EBC

P356

Q35173733-1011913C-BBEE-44A5-9822-3A4DD327797B

P407

Q35173733-43A7D3A9-BD4A-4E78-B0B2-6DC84BA06BFC

P433

Q35173733-B1D580C8-49BA-4179-9CDF-55BF1B0D6A08

P478

Q35173733-72F61BED-4FE3-4D49-876E-B076209423C1

P577

Q35173733-ECA44728-D0F1-4386-B782-AF924997501E

P5875

Q35173733-E8059496-8C27-46A6-BDDC-3B8124B62D6B

P698

Q35173733-01CAA154-1608-48FD-BA8F-E9A9D4B1F790

P932

Q35173733-D8646417-F59A-48C1-B6A2-6A094ECEA0B1

P356

JIMMUNOL.1003057

P1433

Journal of Immunology

P1476

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus

@en

P2093

Amy Moquin

http://www.w3.org/2001/XMLSchema#string

Denise A Kaminski

http://www.w3.org/2001/XMLSchema#string

Frances E Lund

http://www.w3.org/2001/XMLSchema#string

Ho-Tak Lam

http://www.w3.org/2001/XMLSchema#string

Laura Haynes

http://www.w3.org/2001/XMLSchema#string

Mark W LaMere

http://www.w3.org/2001/XMLSchema#string

Troy D Randall

http://www.w3.org/2001/XMLSchema#string

P2860

Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Influenza update 2007-2008: vaccine advances, pandemic preparation

Fcgamma receptors: old friends and new family members

2008-2009 Influenza update: a better vaccine match

Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme

IgG Fc receptors

Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands.

Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

P304

4331-4339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1003057

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50226657

http://www.w3.org/2001/XMLSchema#string

P698

21357542

http://www.w3.org/2001/XMLSchema#string

P932

3159153

http://www.w3.org/2001/XMLSchema#string